Journal profile · Medicine
ACS Bio & Med Chem Au
ISSN 2694-2437 · American Chemical Society · UNITED STATES · Bimonthly · Founded 2021
ACS Bio & Med Chem Au: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 3.5 (journal website); fully open access; APC about USD 3,500; median 84 days to acceptance (97 articles, last 24 months); 83 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
ACS Bio & Med Chem Au is published by American Chemical Society and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Metalloenzymes and iron-sulfur proteins, Academic Writing and Publishing and RNA Interference and Gene Delivery, together about 19.3% of its articles. Its main subfields are Molecular Biology. (generated from OpenAlex topic counts and CAS ranking data)
ACS Bio & Med Chem Au is an open access journal publishing work on all aspects of biological, medicinal and pharmaceutical chemistry. Studies on the chemical, physical, mechanistic, or structural foundations of biological processes - and on the chemical modulation of these processes - are welcome. The journal covers a broad spectrum from basic biochemical research to translational studies and the scope includes theoretically driven work supported by experimental evidence. Submissions in medicinal or pharmaceutical chemistry, as well as research focused on the discovery and validation of molecular targets of disease, are also encouraged. The subjects covered may include but are not limited to the following areas: Chemical biology Medicinal and pharmaceutical chemistry Enzymology Metallobiochemistry Synthetic biology Disease biology Cell biology Agriculture and food Natural products research Nucleic acid biology Neuroscience Structural biology Biophysics Compound design and optimization Biological evaluation Molecular mechanistic understanding of drug delivery and drug delivery systems Imaging agents Radiopharmaceuticals Pharmacology and translational science of small and large bioactive molecules Novel computational, cheminformatics, and structural studies for the identification (or structure-activity relationship analysis) of bioactive molecules, ligands, and their targets Computational studies applying established methods will be considered only in combination with novel experimental data (e.g., in cases where new compounds have been designed and tested). Pathogens Host-pathogen interactions Therapeutics Diagnostics Vaccines Drug-delivery systems Other biomedical technology development pertaining to different diseases and/or disorders.
From the journal's Aims & Scope
Editor-in-chief Shelley D. MinteerDeputyPublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Metalloenzymes and iron-sulfur proteinsEnergy6.5%
- Academic Writing and PublishingArts and Humanities6.5%
- RNA Interference and Gene DeliveryBiochemistry, Genetics and Molecular Biology6.3%
- RNA and protein synthesis mechanismsBiochemistry, Genetics and Molecular Biology6%
- Advanced biosensing and bioanalysis techniquesBiochemistry, Genetics and Molecular Biology5.7%
- Chemical Synthesis and AnalysisBiochemistry, Genetics and Molecular Biology4.6%
- RNA modifications and cancerBiochemistry, Genetics and Molecular Biology4.4%
- Diverse Scientific and Economic StudiesEconomics, Econometrics and Finance4.4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Biochemistry & Molecular Biology | Zone 4 |
| Minor | Chemistry, Medicinal | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Biochemistry & Molecular Biology | Zone 2 |
| Minor | Chemistry, Medicinal | Zone 2 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 3.5Publisher website ·
- 5-year impact factor (publisher)
- 4.4Publisher website ·
- CiteScore 2026-06
- 7.5LetPub ·
- CiteScore (publisher)
- 7.5Publisher website ·
- SJR 2026-06
- 1.27LetPub ·
- SNIP 2026-06
- 0.96LetPub ·
- h-index
- 27OpenAlex ·
- i10-index
- 87OpenAlex ·
- 2-year mean citedness
- 2.97OpenAlex ·
- Self-citation rate
- 2.9%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 65LetPub ·
- Downloads per year (publisher)
- 215,902Publisher website ·
Articles by year OpenAlex count · 332 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 58 | 58 | 9 |
| 2025 | 83 | 83 | 323 |
| 2024 | 52 | 52 | 242 |
| 2023 | 54 | 54 | 573 |
| 2022 | 65 | 65 | 1,260 |
| 2021 | 20 | 20 | 411 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
84 daysMedian, submission to acceptance · P25–P75 65 days – 110 days
- Acceptance to online
- median 12 days (97 articles)
- Submission to online
- median 98 days
- Sample
- 97 articles with submission and acceptance dates (126 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 10 weeksLetPub ·
- First decision after review
- 41.7 daysPublisher website ·
- Submission to acceptance
- 86.9 daysPublisher website ·
- Submission to publication (journal-reported)
- about 17 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 3,500 | Yes | CC BY, CC BY-NC-ND | |
| OpenAlex | USD 3,500 | — | — | |
| LetPub | USD 3,500 | Yes | — | |
| Publisher website | Yes, amount not published | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- American Chemical Society
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Bimonthly
- Founded
- 2021
- ISSN
- 2694-2437
- Latest issue on the website
- Volume 6, Issue 4 (August 2026)
- Official links
- Journal homepage ↗LetPub
- Submission system ↗LetPub
- Author guidelines ↗DOAJ
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about ACS Bio & Med Chem Au
What CAS zone is ACS Bio & Med Chem Au in?
In the 2025 upgraded edition of the CAS Journal Ranking, ACS Bio & Med Chem Au is in Zone 4 of Medicine, and in Zone 4 of the minor category Biochemistry & Molecular Biology / Chemistry, Medicinal. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of ACS Bio & Med Chem Au?
The journal's website gives an impact factor of 3.5; this is the journal's own figure, as LetPub lists none for it; CiteScore 7.5, h-index 27.
How long does peer review take at ACS Bio & Med Chem Au?
Based on the dates recorded on 97 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 84 days (interquartile range 65–110 days); authors report an average review time of about 10 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index ACS Bio & Med Chem Au?
According to LetPub and DOAJ records, ACS Bio & Med Chem Au is indexed in ESCI, Scopus and DOAJ.
Is ACS Bio & Med Chem Au open access, and what is the APC?
ACS Bio & Med Chem Au is a fully open-access journal. APC about USD 3,500.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .